High Adherence to Homeopathic Prophylactic Against COVID-19 in Indian Urban Population

Strategic Insights -

In a response to the COVID-19 pandemic, the Indian government initiated campaigns using complementary therapies, including the large-scale distribution of 30C homeopathic medicine as a potential prophylactic for COVID-19. A multi-center, cross-sectional study conducted across 23 cities in 19 Indian states and union territories from September to November 2022 estimated the individual adherence to using this homeopathic prophylactic within the Indian urban population. The study included 23,101 participants, with 79.89% completing the prescribed three-dose regimen, demonstrating high adherence.

Key Takeaways:

  • The Indian government's initiative to use complementary therapies, including homeopathy, for COVID-19 prevention and control shows promising results, with 79.89% of participants adhering to the prescribed three-dose regimen.
  • Older adults (61 years and above) exhibited the highest adherence rate (84.63%), while younger individuals had lower adherence rates.
  • Employment status, gender, and socio-economic class were significant predictors of adherence, with participants with a lower perceived risk of COVID-19 showing higher adherence rates.
  • The high adherence to 30C highlights the effectiveness of a structured government distribution program and the potential of homeopathy as a welcomed medication in enhancing public health.

Statistics:

  • 23,101 participants completed the survey, with 79.89% (18,457) demonstrating high adherence to the prescribed three-dose regimen.
  • 84.63% of older adults (61 years and above) completed the prescribed regimen, while younger individuals had lower adherence rates.
  • 0.1% (22) of participants reported adverse events, with no serious effects observed.
  • The adjusted odds ratio for participants with a lower perceived risk of COVID-19 was 1.86 (95% confidence interval, 1.73-1.99).

Sources:

  • VerticalNews
  • NewsRx LLC
  • Journal of India
  • Homeopathy (Elsevier) - www.elsevier.com; www.journals.elsevier.com/homeopathy/
  • Department of Clinical Research, Dr. D.P Rastogi Central Research Institute of Homoeopathy, Noida, Uttar Pradesh, India
  • Thieme Medical Publ Inc, 333 Seventh Ave, New York, NY 10001, USA